Selected Drugs Clear All
MultiCheck Results
- 6
Interactions
Monitor/Modify Tx |
||
|
Hydra-Zide
(hydralazine/ hydrochlorothiazide) + Oxtellar XR
(oxcarbazepine) |
||
Monitor/Modify Txhydrochlorothiazide + oxcarbazepine monitor sodium: combo may incr. risk of hyponatremia, seizures (additive effects) |
||
|
Hydra-Zide
(hydralazine/ hydrochlorothiazide) + Parcopa
(carbidopa/ levodopa) |
||
Monitor/Modify Txhydralazine + levodopa monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects) hydrochlorothiazide + levodopa monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects) |
||
|
Hydra-Zide
(hydralazine/ hydrochlorothiazide) + Trandate
(labetalol) |
||
Monitor/Modify Txhydralazine + labetalol monitor BP: combo may incr. risk of severe hypotension (additive effects) |
||
|
Parcopa
(carbidopa/ levodopa) + Trandate
(labetalol) |
||
Monitor/Modify Txlevodopa + labetalol monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects) |
||
Caution Advised |
||
|
Oxtellar XR
(oxcarbazepine) + Parcopa
(carbidopa/ levodopa) |
||
Caution Advisedoxcarbazepine + levodopa caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects) |
||
Additional Considerations |
||
|
levodopa
in Parcopa
|
||
|
add MAO inhibitor to Interaction Check if recent (14 days) use avoid combo with beverages or products containing ethanol and Crexont; combo may incr. levodopa release rate, levels, risk of adverse effects, decr. duration of efficacy |
||
|
carbidopa
in Parcopa
|
||
|
avoid combo with beverages or products containing ethanol and Crexont; combo may incr. carbidopa release rate, levels, risk of adverse effects, decr. duration of efficacy |
||
|
orlistat
in Alli
|
||
|
caution advised with concurrent oral narrow therapeutic index drugs with concerns for loss of efficacy; orlistat may decr. absorption of some oral drugs |
||